Can Synopsys Stock Reach the $700 Milestone This Year?
Synopsys sits at the core of AI driven chip design as investors weigh a path to $700 this year. A debt load from the ...
Learn what to include in your crypto portfolio to maximize returns. Make informed choices for a balanced investment.
23,861 articlesSynopsys sits at the core of AI driven chip design as investors weigh a path to $700 this year. A debt load from the ...
Investors are weighing SpaceX IPO buzz against a broader rotation into blue chips, with traders signaling a shift awa...
Tech stocks retreat sparked a broader market pause, but analysts insist the stock market isn’t crashing — it’s a rota...
AI shares pulled back in a volatile session as rate worries resurfaced. Analysts say Nvidia stock remains a key barom...
A growing number of retirees are considering Chiang Mai, Thailand, on a $500,000 nest egg. The city promises warmth a...
Prediction markets show divergent odds for Stripe, Discord, and Anduril IPOs as of July 2026. Traders weigh S-1 timin...
AI hardware competition now hinges on storage alongside compute. NVIDIA drives data-center growth, while SanDisk ride...
Nvidia unveils a $2 billion investment in Lumentum, pairing strategic scale with a fast-growing demand for AI-grade o...
HPE reports a landmark shift in its earnings mix, with networking revenue over half of profits amid the Juniper Netwo...
Ford’s global footprint is narrowing as European and Chinese demand falters, leaving the US as the main growth engine...
A new wave of fiber-infused sodas and gummies is hitting shelves as 'fibermaxxing' spurred a fiber push across snacks...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...